KALA BIO, Inc.
KALA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001479419
No open-market purchases or sales by KALA BIO, Inc. insiders were filed in the last 90 days; 15 institutions reported holding it in 13F filings for Q2 2026, worth $1.21M in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in KALA BIO, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 30
- −26 vs. Q3 2022
- Shares held
- 336.2K
- +212.9K (+172.6%) vs. Q3 2022Converted for a 1-for-50 split
- Total value
- $12.8M
- +$11.5M (+843.2%) vs. Q3 2022
- New holders
- 6
- 9 more added
- Sold out
- 32
- 6 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting KALA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 15 | $1.21M |
| Q1 2026 | 30 | $294.0K |
| Q4 2025 | 32 | $1.58M |
| Q3 2025 | 24 | $2.69M |
| Q2 2025 | 30 | $17.3M |
| Q1 2025 | 29 | $23.7M |
| Q4 2024 | 33 | $24.0M |
| Q3 2024 | 27 | $12.1M |
| Q2 2024 | 29 | $14.8M |
| Q1 2024 | 29 | $4.88M |
| Q4 2023 | 25 | $3.68M |
| Q3 2023 | 26 | $4.57M |
| Q2 2023 | 30 | $5.56M |
| Q1 2023 | 26 | $4.81M |
| Q4 2022 | 30 | $12.8M |
| Q3 2022 | 56 | $1.36M |
| Q2 2022 | 70 | $2.27M |
| Q1 2022 | 88 | $33.7M |
| Q4 2021 | 85 | $30.9M |
| Q3 2021 | 108 | $79.5M |
| Q2 2021 | 107 | $171.3M |
| Q1 2021 | 118 | $248.9M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding KALA BIO, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Parallel Advisors, LLC | 1 | $38 | 0.00% | 00.0% | UnchangedConverted for a 1-for-50 split |
| Worth Asset Management, LLC | 10 | $382 | 0.00% | 00.0% | UnchangedConverted for a 1-for-50 split |
| Wells Fargo & Company | 69 | $2.63K | 0.00% | −49−41.5% | ReducedConverted for a 1-for-50 split |
| Tower Research Capital LLC (TRC) | 90 | $3.00K | 0.00% | −691−88.5% | ReducedConverted for a 1-for-50 split |
| Steward Partners Investment Advisory, LLC | 120 | $4.58K | 0.00% | 00.0% | UnchangedConverted for a 1-for-50 split |
| Covestor Ltd | 220 | $8.00K | 0.01% | −9−4.1% | ReducedConverted for a 1-for-50 split |
| MCF Advisors LLC | 230 | $8.77K | 0.00% | +230 | New |
| Advisor Group Holdings, Inc. | 234 | $9.00K | 0.00% | −11−4.6% | ReducedConverted for a 1-for-50 split |
| Group One Trading, L.P. | 305 | $11.6K | 0.00% | +6+2.0% | AddedConverted for a 1-for-50 split |
| UBS Group AG | 310 | $11.8K | 0.00% | −1,153−78.8% | ReducedConverted for a 1-for-50 split |
| Compagnie Lombard Odier SCmA | 400 | $15.0K | 0.00% | 00.0% | UnchangedConverted for a 1-for-50 split |
| Citigroup Inc | 475 | $18.1K | 0.00% | +178+60.1% | AddedConverted for a 1-for-50 split |
| JPMorgan Chase & Co | 565 | $21.0K | 0.00% | +533+1,684.6% | AddedConverted for a 1-for-50 split |
| Royal Bank of Canada | 669 | $25.0K | 0.00% | +637+1,994.6% | AddedConverted for a 1-for-50 split |
| Banque Cantonale Vaudoise | 1,508 | $58.0K | 0.00% | 00.0% | UnchangedConverted for a 1-for-50 split |
| Morgan Stanley | 2,094 | $79.9K | 0.00% | +28+1.4% | AddedConverted for a 1-for-50 split |
| Knights of Columbus Asset Advisors LLC | 2,417 | $92.2K | 0.01% | +2,417 | New |
| Two Sigma Securities, LLC | 6,517 | $248.6K | 0.04% | +6,517 | New |
| Geode Capital Management, LLC | 8,936 | $340.0K | 0.00% | 00.0% | UnchangedConverted for a 1-for-50 split |
| State Street Corp | 9,986 | $381.0K | 0.00% | +7,700+336.8% | AddedConverted for a 1-for-50 split |
| Vanguard Group Inc | 10,196 | $389.0K | 0.00% | −13,563−57.1% | ReducedConverted for a 1-for-50 split |
| Renaissance Technologies LLC | 10,592 | $404.0K | 0.00% | +1,856+21.2% | AddedConverted for a 1-for-50 split |
| Board of Trustees of The Leland Stanford Junior University | 11,379 | $434.1K | 0.04% | 00.0% | UnchangedConverted for a 1-for-50 split |
| Samsara BioCapital, LLC | 12,024 | $458.7K | 0.10% | 00.0% | UnchangedConverted for a 1-for-50 split |
| Bank of America Corp | 13,284 | $506.8K | 0.00% | +13,196+14,961.2% | AddedConverted for a 1-for-50 split |
| BlackRock Inc. | 15,707 | $599.2K | 0.00% | 00.0% | UnchangedConverted for a 1-for-50 split |
| Jane Street Group, LLC | 25,953 | $990.1K | 0.00% | +25,953 | New |
| Clear Street LLC | 49,390 | $1.88M | 0.07% | +49,390 | New |
| Millennium Management LLC | 75,696 | $2.89M | 0.00% | +64,537+578.3% | AddedConverted for a 1-for-50 split |
| Baker Bros. Advisors LP | 76,813 | $2.93M | 0.02% | +76,813 | New |
| Vahanian & Associates Financial Planning Inc. | 0 | $0 | 0.00% | −4,149−100.0% | Sold outConverted for a 1-for-50 split |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −2,674−100.0% | Sold outConverted for a 1-for-50 split |
| Price T Rowe Associates Inc | 0 | $0 | 0.00% | −1,810−100.0% | Sold outConverted for a 1-for-50 split |
| Northern Trust Corp | 0 | $0 | 0.00% | −1,649−100.0% | Sold outConverted for a 1-for-50 split |
| Virtu Financial LLC | 0 | $0 | 0.00% | −1,297−100.0% | Sold outConverted for a 1-for-50 split |
| Oppenheimer & Co Inc | 0 | $0 | 0.00% | −1,232−100.0% | Sold outConverted for a 1-for-50 split |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −1,034−100.0% | Sold outConverted for a 1-for-50 split |
| Man Group plc | 0 | $0 | 0.00% | −924−100.0% | Sold outConverted for a 1-for-50 split |
| Greenwich Wealth Management LLC | 0 | $0 | 0.00% | −596−100.0% | Sold outConverted for a 1-for-50 split |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −617−100.0% | Sold outConverted for a 1-for-50 split |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −562−100.0% | Sold outConverted for a 1-for-50 split |
| FMR LLC | 0 | $0 | 0.00% | −400−100.0% | Sold outConverted for a 1-for-50 split |
| Wedbush Securities Inc | 0 | $0 | 0.00% | −406−100.0% | Sold outConverted for a 1-for-50 split |
| Bank of New York Mellon Corp | 0 | $0 | 0.00% | −381−100.0% | Sold outConverted for a 1-for-50 split |
| Susquehanna Fundamental Investments, LLC | 0 | $0 | 0.00% | −335−100.0% | Sold outConverted for a 1-for-50 split |
| GSB Wealth Management, LLC | 0 | $0 | 0.00% | −400−100.0% | Sold outConverted for a 1-for-50 split |
| Csenge Advisory Group | 0 | $0 | 0.00% | −398−100.0% | Sold outConverted for a 1-for-50 split |
| IPG Investment Advisors LLC | 0 | $0 | 0.00% | −286−100.0% | Sold outConverted for a 1-for-50 split |
| Peapack Gladstone Financial Corp | 0 | $0 | 0.00% | −274−100.0% | Sold outConverted for a 1-for-50 split |
| HRT Financial LP | 0 | $0 | 0.00% | −301−100.0% | Sold outConverted for a 1-for-50 split |
| Creative Planning | 0 | $0 | 0.00% | −284−100.0% | Sold outConverted for a 1-for-50 split |
| Kestra Advisory Services, LLC | 0 | $0 | 0.00% | −242−100.0% | Sold outConverted for a 1-for-50 split |
| StoneX Group Inc. | 0 | $0 | 0.00% | −270−100.0% | Sold outConverted for a 1-for-50 split |
| Commonwealth Equity Services, LLC | 0 | $0 | 0.00% | −204−100.0% | Sold outConverted for a 1-for-50 split |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −215−100.0% | Sold outConverted for a 1-for-50 split |
| FineMark National Bank & Trust | 0 | $0 | 0.00% | −200−100.0% | Sold outConverted for a 1-for-50 split |
| Evoke Wealth, LLC | 0 | $0 | 0.00% | −160−100.0% | Sold outConverted for a 1-for-50 split |
| BNP Paribas Arbitrage, SA | 0 | $0 | 0.00% | −119−100.0% | Sold outConverted for a 1-for-50 split |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −50−100.0% | Sold outConverted for a 1-for-50 split |
| Aquatic Capital Management LLC | 0 | $0 | 0.00% | −78−100.0% | Sold outConverted for a 1-for-50 split |
| First Manhattan Co | 0 | $0 | 0.00% | −38−100.0% | Sold outConverted for a 1-for-50 split |
| Investors Asset Management of Georgia Inc | 0 | $0 | 0.00% | −10−100.0% | Sold outConverted for a 1-for-50 split |